NFKB1 and cancer: Antibody deficient patients mainly with defective PI3K or NFKB pathways can develop several different cancer predisposing means including avoiding immune destruction, resisting cell death, inducing angiogenesis, deregulating cellular energies, activating invasion and metastasis, tumor promoting inflammation, and enabling replicative immortality.